$WEAT

Teucrium Wheat Fund (NYSE Arca: WEAT) prospectus outlines 25,000-share baskets and 1.00% fee

The Teucrium Wheat Fund (WEAT) filed a prospectus detailing its continuous public offering of shares on NYSE Arca. The fund issues Creation Baskets of 25,000 shares to Authorized Purchasers, aims to track the Teucrium Wheat Index (TWEAT) by investing in wheat futures and cash equivalents, and charges a 1.00% annual management fee. The prospectus highlights key figures such as Creation Basket size, management fees, and a breakeven point, along with principal risks including tracking error, contango/backwardation, and liquidity.

Original reporting
Published May 1, 2026, 5:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 1, 2026, 6:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$WEAT
Neutral
medium confidence
Mentioned
$WEAT
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$WEATNeutralLow
01

Why it matters

The detailed prospectus highlights operational structure and risks, which are important for assessing long-term investment suitability but have limited short-term trading implications.

02

Market read

While informative for investors and analysts, the news has limited immediate impact on wheat prices or related securities.

03

What to watch

Market reaction to the fund's performance and broader commodity price trends could overshadow the structural details outlined in the prospectus.

Timing: short-term

Background

The Teucrium Wheat Fund (WEAT) aims to provide investors with exposure to wheat futures by issuing Creation Baskets of 25,000 shares, tracking the Teucrium Wheat Index.

Company-level read

Ticker impact

$WEATNeutralMedium confidence
Context

Primary focus of the news, as it discusses the Teucrium Wheat Fund (WEAT).

Expected impact

Limited immediate impact; potential for moderate price adjustments based on fund performance and market conditions.

Evidence & confidence

The news provides factual details about the fund's structure and risks, but does not indicate immediate market movements or fundamental changes affecting wheat prices.

Market effects

Potential influence on agricultural commodities sector, especially wheat futures and related ETFs.

Limited; primarily affects US-based wheat futures markets and investors.

Minimal; the fund's structure and risks are specific to US markets and do not directly impact global wheat prices.

Counterpoint

The detailed prospectus may signal increased investor interest, potentially leading to increased liquidity and reduced spreads for WEAT.

Key entities

  • Teucrium Wheat Fund

    A commodity-focused ETF tracking wheat futures.

  • Teucrium Wheat Index

    The benchmark index for WEAT, representing wheat futures.

Related articles

$WEATMed

Wheat Hits Three-Year High as Corn Slips

Wheat prices surged to three-year highs on August 27, 2026, due to escalating tensions in the Russia-Ukraine war. The wheat-tracking fund WEAT rose 0.85% to US$27.22. Corn prices fell 1.15% to US$19.80, while soybeans saw a slight gain of 0.04% to US$26.76. The shifts were driven by supply concerns and China's preference for soybeans over corn.

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.